Furthermore, knockdown of SIK3 with siRNA (specificity of siRNA to silence SIK3 is demonstrated in latter section) has reduced the cell proliferation by upto 25%, supporting our previous claim that co-treatment of high salt with IL-17 induces upregulation of breast cancer cell proliferation. The gene discussed is IL17A; the disease is breast carcinoma.